About TPG

• Founded: 1992

• Headquarters: Fort Worth, Texas and San Francisco, California

• AUM: $229bn (as of 2024)

• Strategy: Large-cap buyout and growth equity across technology, healthcare, consumer, and financial services, globally

• Track record: Fund IX closed at $15bn in 2022; first healthcare fund launched in 2021 at $6bn; second healthcare fund closed at $10bn in 2024

• Leadership: Jon Winkelried (CEO) and Jim Coulter (Co-Founder)

TPG has raised the majority of its $17bn target for TPG X, its tenth flagship fund, alongside its third healthcare fund, both launched in mid-2025. The two vehicles are part of the firm's $94bn Capital platform, which focuses on large-scale global buyout and growth equity. The $17bn target for Fund X represents a 13% increase over its predecessor, which closed at $15bn in 2022.

A $17bn close in this environment carries weight — few firms outside KKR, Blackstone, and Apollo are pulling targets north of $15bn. TPG's ability to scale Fund X from a $15bn predecessor while simultaneously raising a third healthcare fund suggests LP wallets remain open for managers with demonstrated sector expertise and deployment discipline. The healthcare fund sequence is particularly telling: the firm moved from $6bn to $10bn between funds I and II, and launching fund III while still in market for the flagship signals confidence in both sector tailwinds and the team's ability to deploy at pace.

The open question is deployment velocity. TPG deployed Fund IX over roughly three years, a clip that works at $15bn but gets harder at $17bn without adding partners or widening the aperture on deal size. The firm's recent move into continuation vehicles and GP-led secondaries offers one release valve, but if Fund X follows the same four-to-five-year fundraise-to-final-close cadence as its predecessor, the pressure to put capital to work while maintaining selectivity will define the next vintage's performance. Watch whether TPG leans harder into take-privates or scales check sizes in growth equity — both paths have worked for the platform, but the balance will matter.

Source: Private Equity International